S

SSY Group Ltd
HKEX:2005

Watchlist Manager
SSY Group Ltd
HKEX:2005
Watchlist
Price: 3.73 HKD -2.1% Market Closed
Market Cap: 11B HKD
Have any thoughts about
SSY Group Ltd?
Write Note

SSY Group Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SSY Group Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
S
SSY Group Ltd
HKEX:2005
Retained Earnings
HK$7.8B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
17%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Retained Earnings
HK$15.7B
CAGR 3-Years
43%
CAGR 5-Years
45%
CAGR 10-Years
39%
U
United Laboratories International Holdings Ltd
HKEX:3933
Retained Earnings
ÂĄ13.5B
CAGR 3-Years
37%
CAGR 5-Years
29%
CAGR 10-Years
17%
Sino Biopharmaceutical Ltd
HKEX:1177
Retained Earnings
ÂĄ22.5B
CAGR 3-Years
24%
CAGR 5-Years
6%
CAGR 10-Years
22%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Retained Earnings
HK$25.7B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Retained Earnings
-$845.1m
CAGR 3-Years
-18%
CAGR 5-Years
-30%
CAGR 10-Years
-29%
No Stocks Found

SSY Group Ltd
Glance View

Market Cap
11.1B HKD
Industry
Pharmaceuticals

SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 4,800 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.

Intrinsic Value
5.41 HKD
Undervaluation 31%
Intrinsic Value
Price
S

See Also

What is SSY Group Ltd's Retained Earnings?
Retained Earnings
7.8B HKD

Based on the financial report for Jun 30, 2024, SSY Group Ltd's Retained Earnings amounts to 7.8B HKD.

What is SSY Group Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
17%

Over the last year, the Retained Earnings growth was 12%. The average annual Retained Earnings growth rates for SSY Group Ltd have been 13% over the past three years , 13% over the past five years , and 17% over the past ten years .

Back to Top